NanoEnTek, Inc.

NanoEntek has key technology of nano scale Bio-MEMS that organizationally combined microelectromechanical system(MEMS) and biotechnology called technology of 21st century. Based on the technology, we are expanding business to life science experiment equipment, medical in-vitro diagnostic device, and related solution development. There are about 100 patents of nano convergence technology that were applied and registered. Especially, one of our company’s key platforms is lab-on-a-chip, and it is a next generation technology that will contribute in medicine and life science areas.

We will develop as a global leader, sharing innovation.

[Success of cell counters] In life science The first successful products was Countess™, the world's first personal cell counter which was a shift in paradigm of cell counters. Following this success, it developed the series of other cell counters; EVE series for academic laboratory, ADAM™ CellT cell counter for cGMP facility, and ADAMII™ LS novel fluorescence cell counter/analyzer.

The second success came from ADAM™ rWBC, the world's first benchtop residual white blood cell counter with FDA 510(k) cleared. It has been selected as the QC standard equipment of the American Red Cross(ARC) and installed in more than 200 blood banks globally.

Through the strong performance (high-accuracy, speed and usability) and customer’s satisfaction, we launched 6 new products in 2023 including EVE™ HT FL (High-Throughput Fluorescence Cell Counter) and JuLI™ Stage (Real-time live cell imaging system). They can even fulfill all your needs as well from the research level to the large-scale multi-site manufacturing.